AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$OPCH

Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share

Option Care Health (OPCH) agreed to a $32.05 per share cash acquisition by CD&R and McKesson (MCK), valuing the company at $5.8 billion. The deal represents a 37% premium to OPCH's October 5 closing price. CD&R will own 51%, McKesson 49%. The transaction is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 2:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 3:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The acquisition creates a vertically integrated platform for specialty therapies, potentially improving margins and market reach.

02

Market read

The deal is a material M&A event that will immediately affect OPCH pricing and may modestly influence McKesson's strategic outlook.

03

What to watch

Potential integration challenges and the impact of future equity‑method accounting on McKesson's earnings.

Relevance 9/10Novelty 9/10Timing: immediate, pre‑market reaction today

Background

Option Care Health operates a national network of home and alternate‑site infusion services; McKesson is a leading healthcare services distributor.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive cash acquisition at $32.05 per share, a 37% premium, making the deal the primary news of the article.

Expected impact

upward pressure as the stock trades toward the $32.05 offer price

Evidence & confidence

The deal is newly disclosed, sizable ($5.8 B) and includes a premium, driving immediate price appreciation before the stock ceases trading.

$MCKNeutralMedium confidence
Context

McKesson is a co‑buyer in the $5.8 B acquisition of Option Care Health, committing $1.4 B for a 49% stake.

Expected impact

slight positive pressure as investors value the strategic fit

Evidence & confidence

The transaction adds a new business line but the cash outlay is modest relative to McKesson’s size, so impact is limited.

Market effects

Sector

Healthcare services sector may see increased M&A activity as larger players seek home‑infusion capabilities.

Regional

U.S. healthcare market gains a larger integrated provider, potentially boosting related stocks.

Global

The deal underscores consolidation trends in global specialty therapy distribution.

Counterpoint

What could challenge this read

If regulatory approvals stall, the premium could evaporate, leaving investors exposed to a failed transaction.

Key entities

  • Company
    Option Care Health

    Target of the $5.8 B acquisition.

  • Company
    McKesson Corp.

    Co‑buyer committing $1.4 B for a 49% stake.

  • Private Equity
    CD&R

    Seller holding 51% post‑deal.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min